LiquidSMARTS℠ notes that CMS proposed removing the hospital and operator volume minimums that have decided which hospitals are allowed to run a TAVR program since 2019 on June 15.
Public source
Publisher name
Public post
Edwards raised its TAVR guidance on July 23. Eleven days from now, CMS decides something that matters more to your 2027 territory than that number does. TAVR is 74 perce…
Company
LiquidSMARTS℠
Sales coaching for MedTech & Healthcare pros, helping you communicate better, lead with confidence, and grow your career
- Industry
- Professional Training and Coaching
- Location
- Chattanooga, US
- Company size
- 2–10 employees
About LiquidSMARTS℠
We transform MedTech and healthcare sales teams into high-performing leaders with proven training and strategies. OUR OUTCOMES AREN’T JUST PROMISED; THEY’RE PROVEN • $4B+ Market cap growth for clients • Over 50K Salespeople Trained • 100+ Promotions to Executive Roles through our Coaching Programs Our tailored approach fuels growth, leadership, and market dominance. Ready to elevate your team? Let’s build your success story.
See moreLatest activity
Latest activity from LiquidSMARTS℠
4 signals
Legal & Regulatory
LiquidSMARTS℠ notes that Medicare Advantage organizations are now required to publish prior authorization items and eight metrics covering approval rates, denial rates, appeal outcomes, and decision turnaround times under the CMS interoperability and prior authorization rule effective on April 1.
Products & Services
LiquidSMARTS℠ split autonomy from authority for AI agents, allowing unlimited freedom on cognition and zero freedom on external action.
Research & Knowledge
LiquidSMARTS℠ logged every post for five months, classified each one before it went out, and scored it at 48 hours.
Discover more
Similar signals
Similar public activity from other companies.
Legal & Regulatory
Echopoint Medical Ltd
Echopoint Medical Ltd announced that its iKOr system, designed to make vasospasm diagnosis faster and easier, has been FDA-approved.
Legal & Regulatory
InnovHeart
InnovHeart announced the implantation of the first U.S. patient with the Saturn Transseptal TMVR System at NewYork-Presbyterian/Columbia University Irving Medical Center in New York as part of the CASSINI-US Early Feasibility Study.
Legal & Regulatory
Reflow Medical
Reflow Medical announced that CMS has approved a New Technology Add-on Payment (NTAP) for the FDA Breakthrough Device-designated Spur Peripheral Retrievable Stent System effective for discharges on or after October 1, 2026.
Legal & Regulatory
RepPrep.ai
RepPrep.ai notes that the CY2026 CMS final rule is 3,000+ pages and most of it won't come up on a call.
Legal & Regulatory
Johnson & Johnson MedTech